Home
Broadwood Partners reported a 39.7% stake in Insight Molecular Diagnostics IMDX · 12,835,134 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 39.7%
- Last report
- 37.4% · filed 26/02/12
- Shares held
- 12,835,134 sh
- Class
- Common Stock, no par value
- Holder
- Broadwood Partners
- Event date
- 26/04/23
- Filed
- 26/04/27
39.7% stake · +2.3pp from the last report
- Stake
- 39.7%
- Last report
- 37.4%
- Since last report
- +2.3pp
Insight Molecular Diagnostics trades, last 26 weeks
What else happened in Insight Molecular Diagnostics around then
Filed or reported within 30 days of the trade day · 03/24~05/23Broadwood Partners's other 5% stake reports
- Broadwood Partners
5% stakeStaar Surgical
5% stakeStaar Surgical
STAA
32.6% stake
16,149,742 sh
32.6% stake
Filed 03/13
- Broadwood Partners
5% stakeInsight Molecular Diagnostics
5% stakeInsight Molecular Diagnostics
IMDX
37.4% stake
12,082,089 sh
37.4% stake
Filed 02/12
- Broadwood Partners
5% stakeStaar Surgical
5% stakeStaar Surgical
STAA
31.1% stake
15,479,529 sh
31.1% stake
Filed 01/16
- Broadwood Partners
5% stakeStaar Surgical
5% stakeStaar Surgical
STAA
30.2% stake
15,045,391 sh
30.2% stake
Filed 25/12/17
- Broadwood Partners
5% stakeStaar Surgical
5% stakeStaar Surgical
STAA
30.2% stake
15,045,391 sh
30.2% stake
Filed 25/11/21
